Treatment of bipolar disorders and associated symptoms

Details for Australian Patent Application No. 2004237961 (hide)

Owner Pfizer Products Inc.

Inventors Harrigan, Edmund; Heym, James Herbert; Seeger, Thomas Francis; Giller, Earl Laux Jr.; Romano, Steven Joseph

Agent Allens Arthur Robinson

Pub. Number AU-A-2004237961

PCT Pub. Number WO2004/100957

Priority 60/471,450 16.05.03 US

Filing date 12 May 2004

Wipo publication date 25 November 2004

International Classifications

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 025/00 Drugs for disorders of the nervous system

A61P 025/24 Drugs for disorders of the nervous system

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/100957 Priority application(s): WO2004/100957

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237967-Sound massage system

2004237958-Hard gelatin capsule containing titanium oxide with a controlled particle size and process for producing the same